Objective Ménière's disease (MD) is a clinical condition defined by spontaneous vertigo
attacks (each lasting 20 minutes to 12 hours) with documented low‐to midfrequency …

This article reviews the effectiveness of intratympanic corticosteroids for vertigo control in
Ménière's disease at 2-years follow-up according to the guidelines expressed by the …

Background Ménière's disease is a condition that causes recurrent episodes of vertigo,
associated with hearing loss and tinnitus. A number of pharmacological interventions have …

Background Meniere's disease (MD) is a chronic condition of the inner ear consisting of
symptoms that include vertigo attacks, fluctuating sensorineural hearing loss, tinnitus and …

Background Ménière's disease is a condition that causes recurrent episodes of vertigo,
associated with hearing loss and tinnitus. Corticosteroids are sometimes administered …

Dexamethasone (DEX) can reduce fibrous tissue growth as well as loss of residual hearing
which may occur after cochlear implantation. Little is known about the effect of local inner …

Purpose Intratympanic (IT) drug delivery receives attention due to its effectivity in treatment
for Menière's disease (MD). Due to the release of the consensuses and new evidence on IT …

Vertigo is associated with a wide range of vestibular pathologies. It increasingly affects the
elderly, with a high cost to society. Solutions include vestibular suppressants and vestibular …

The stria vascularis (SV) contributes to cochlear homeostasis and consists of three layers,
one of which contains the blood-labyrinthic barrier (BLB), with a large number of bovine …

Histamine [H] is a well-known biogenic amine whose biological properties were first
characterized more than 100 years ago [1, 2]. It plays a significant role in the human …